KalVista Pharmaceuticals, Inc. (KALV)
26.79
-0.02
(-0.07%)
USD |
NASDAQ |
May 27, 16:00
26.81
+0.02
(+0.07%)
After-Hours: 20:00
KalVista Pharmaceuticals Profit Margin (Quarterly) : -57.48% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -639.5% |
| Sensei Biotherapeutics, Inc. | -- |
| Recursion Pharmaceuticals, Inc. | -1.82K% |
| BioCryst Pharmaceuticals, Inc. | -461.5% |
| Anika Therapeutics, Inc. | -17.07% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -529.1% |
| Return on Assets | -47.07% |
| Return on Invested Capital | -56.16% |
| Gross Profit Margin (Quarterly) | 91.57% |
| Operating Margin (Quarterly) | -57.37% |
| Return on Net Operating Assets | -696.2% |